National Research Corporation

NASDAQ:NRC

Medical - Healthcare Information Services

Healthcare
$26.16 +0.40%

+$0.07 today

Market cap
$555.16M
Beta
0.40
P/E (TTM)
43.0
EPS (TTM)
$0.41
Dividend yield
3.14%
52W Low $11.01High $22.79

Volume 0.09M

Average 0.11M

NRC Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

National Research CorporationNASDAQ: NRC

Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026

Depreciation & amortization growth accelerates

Q1 FY2026 depreciation & amortization of $2.17M rose 40.7% year over year, ahead of the +34.9% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 1.1% from the prior quarter. Over 3 fiscal years it compounded at +13.0% a year.

Context

  • Depreciation & amortization amounted to 5.5% of revenue in FY2025, up 1.3 pp from a year earlier.
  • Depreciation & amortization increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +40.7% holds above the trailing-twelve-month pace of +34.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.17M+1.1% QoQ
Last fiscal yearDec 2025
$7.62M+26.6% YoY
LTMMar 2026
$8.25M+34.9% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+40.7%——
1 year+26.6%——
3-year CAGR+13.0%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the income statement

Latest · FY2025
7.62M USD
Year-over-year change
+26.6%
4-year CAGR
+4.6%

Depreciation & Amortization vs competitors

How NRC compares with its peers on the latest reported figures

  • NRC's LTM Mar 2026 depreciation & amortization of $8.25M is the lowest of the 8 companies compared; the peer median is $44.09M.
  • Its year-over-year change of +34.9% is the highest of 8, against a peer median of +5.8%.
  • Depreciation & amortization amounts to 6.0% of revenue for NRC, versus a peer median of 14.4%.
NRC Competitors Peer median
Depreciation & Amortization for NRC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CTEVClaritev CorporationLTM Mar 2026$447.88M +1.8%+2.6%45.8%
DHDefinitive Healthcare Corp.LTM Mar 2026$50.86M -3.7%-14.3%21.3%
HCATHealth Catalyst, Inc.LTM Mar 2026$50.3M +16.4%-0.7%16.6%
HSTMHealthStream, Inc.LTM Mar 2026$44.09M +5.8%+4.6%14.1%
PHRPhreesia, Inc.LTM Apr 2026$34.65M +22.0%+3.0%7.0%
CCLDCareCloud, Inc.LTM Mar 2026$17.82M +30.0%+4.2%14.4%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$8.65M -2.0%+19.6%10.7%
NRCNational Research CorporationLTM Mar 2026$8.25M +34.9%+13.0%6.0%
Peer median (excluding NRC) $44.09M+5.8%+3.0%14.4%

Competitors are the stored peer set for NRC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue147.95M151.57M148.58M143.06M137.39M
Cost of Revenue52.35M57.05M56.02M56.93M60M
Gross Profit95.6M94.52M92.57M86.13M77.4M
Gross Margin64.6%62.4%62.3%60.2%56.3%
Research & Development00000
Selling, General & Admin38.96M42.7M46.58M44.91M54.81M
Operating Expenses45.33M47.98M52.52M50.93M54.81M
Depreciation & Amortization6.37M5.28M5.9M6.02M7.62M
EBITDA56.66M49.3M45.99M41.31M30.23M
EBITDA Margin38.3%32.5%30.9%28.9%22.0%
Operating Income50.27M46.54M40.05M35.19M22.59M
Operating Margin34.0%30.7%27.0%24.6%16.4%
Interest Income14K168K820K125K111K
Interest Expense1.67M1.21M862K2.6M4.76M
Other Income / Expenses(1.65M)(3.73M)(83K)(2.5M)(4.75M)
Income Before Tax48.62M42.82M39.96M32.69M17.84M
Pre-Tax Margin32.9%28.2%26.9%22.9%13.0%
Income Tax Expense11.16M11.02M8.99M7.91M6.24M
Net Income37.47M31.8M30.97M24.78M11.6M
Net Margin25.3%21.0%20.8%17.3%8.4%
EPS (Basic)1.471.281.261.050.52
EPS (Diluted)1.461.271.251.040.52
Weighted Avg Shares25.42M24.92M24.54M23.72M22.38M
Weighted Avg Shares (Diluted)25.64M25.05M24.67M23.74M22.4M

National Research Corporation

NASDAQ:NRC

Intrinsic Alpha fair value

Locked

Current Price

$26.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.